The Improvement of Survival in Metastatic NSCLC - Chair: Rolf Stahel
- Egbert Smit: Targeted Therapy for Patients with Oncogenic Driver NSCLC
- Alessandra Curioni: Immune Checkpoint Inhibition for Patients with Tumors lacking Oncogenic Drivers
- Discussion